Li Shen Selected Research

aspernigerin

5/2006

Structure and total synthesis of aspernigerin: a novel cytotoxic endophyte metabolite.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Li Shen Research Topics

Disease

135	Neoplasms (Cancer) 01/2022 - 06/2002
49	Alzheimer Disease (Alzheimer's Disease) 01/2022 - 05/2007
27	Inflammation (Inflammations) 01/2023 - 03/2006
24	Heart Failure 01/2022 - 01/2005
22	Stomach Neoplasms (Stomach Cancer) 01/2021 - 03/2011
21	Neoplasm Metastasis (Metastasis) 08/2021 - 08/2008
18	Infections 01/2022 - 05/2003
16	Breast Neoplasms (Breast Cancer) 01/2022 - 12/2010
16	Lung Neoplasms (Lung Cancer) 01/2021 - 01/2006
16	Cognitive Dysfunction 09/2020 - 08/2009
15	Fibrosis (Cirrhosis) 05/2022 - 02/2011
13	Carcinoma (Carcinomatosis) 01/2022 - 05/2006
13	Type 2 Diabetes Mellitus (MODY) 01/2022 - 12/2012
13	Body Weight (Weight, Body) 09/2021 - 02/2007
13	Cardiovascular Diseases (Cardiovascular Disease) 12/2020 - 04/2010
12	Carcinogenesis 01/2022 - 07/2009
12	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 11/2021 - 01/2010
12	Myocardial Infarction 04/2021 - 05/2007
11	Thrombosis (Thrombus) 01/2023 - 10/2006
11	Atherosclerosis 01/2022 - 05/2013
11	Renal Cell Carcinoma (Grawitz Tumor) 01/2020 - 06/2010
11	Glioma (Gliomas) 02/2019 - 01/2010
10	Brain Diseases (Brain Disorder) 01/2022 - 03/2010
10	Atrophy 01/2022 - 08/2010
10	Glioblastoma (Glioblastoma Multiforme) 11/2021 - 01/2011
10	Hypoxia (Hypoxemia) 01/2021 - 01/2012
9	Liver Cirrhosis (Hepatic Cirrhosis) 12/2021 - 03/2006
9	Prostatic Neoplasms (Prostate Cancer) 01/2021 - 01/2008
8	COVID-19 01/2022 - 01/2020
8	Obesity 01/2021 - 11/2008
8	Hepatocellular Carcinoma (Hepatoma) 01/2021 - 01/2005
8	Colorectal Neoplasms (Colorectal Cancer) 01/2021 - 05/2006
8	Coronary Artery Disease (Coronary Atherosclerosis) 01/2020 - 05/2003
7	Hyperplasia 01/2023 - 07/2011
7	Pain (Aches) 07/2022 - 06/2013
7	Schizophrenia (Dementia Praecox) 01/2022 - 04/2012
7	Atherosclerotic Plaque (Atheroma) 04/2021 - 02/2010
7	Hypertension (High Blood Pressure) 01/2020 - 05/2010
7	Squamous Cell Carcinoma of Head and Neck 01/2019 - 01/2013
6	Communicable Diseases (Infectious Diseases) 01/2022 - 01/2018
6	Infarction (Infarctions) 01/2022 - 10/2011
6	Lung Injury 01/2019 - 03/2007
5	Acute Lung Injury 02/2022 - 02/2007
5	Ischemic Stroke 01/2022 - 08/2012
5	Lymphatic Metastasis 08/2021 - 08/2008
5	Muscular Diseases (Myopathy) 01/2020 - 01/2018

Drug/Important Bio-Agent (IBA)

67	Biomarkers (Surrogate Marker)IBA 01/2022 - 03/2010
56	Proteins (Proteins, Gene)FDA Link 04/2022 - 08/2003
33	Pharmaceutical PreparationsIBA 01/2022 - 06/2002
21	Biological ProductsIBA 01/2022 - 12/2012
16	MicroRNAs (MicroRNA)IBA 01/2022 - 01/2013
16	Amyloid (Amyloid Fibrils)IBA 01/2022 - 05/2007
15	Messenger RNA (mRNA)IBA 01/2022 - 09/2007
13	CytokinesIBA 01/2022 - 11/2007
12	Polysaccharides (Glycans)IBA 01/2021 - 01/2012
12	Apolipoproteins E (ApoE)IBA 12/2020 - 01/2013
12	Insulin (Novolin)FDA Link 01/2019 - 07/2010
11	RNA (Ribonucleic Acid)IBA 01/2022 - 04/2016
10	EnzymesIBA 01/2022 - 11/2012
10	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 06/2002
10	LipidsIBA 01/2022 - 02/2014
10	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2021 - 06/2007
9	ChromatinIBA 01/2022 - 01/2008
9	ErbB Receptors (EGF Receptor)IBA 02/2019 - 01/2010
8	CholesterolIBA 01/2022 - 05/2010
8	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 10/2009
8	oxidized low density lipoproteinIBA 01/2021 - 05/2013
8	Tyrosine Kinase InhibitorsIBA 01/2021 - 06/2010
8	CollagenIBA 01/2018 - 02/2010
7	Cocaine (Cocaine HCl)IBA 04/2022 - 02/2011
7	Phosphotransferases (Kinase)IBA 01/2022 - 01/2010
6	Sirolimus (Rapamycin)FDA Link 01/2023 - 03/2015
6	VaccinesIBA 01/2022 - 01/2012
6	sacubitril and valsartan sodium hydrate drug combinationIBA 01/2022 - 01/2017
6	Therapeutic UsesIBA 12/2021 - 02/2010
6	Small Interfering RNA (siRNA)IBA 01/2021 - 01/2011
6	ApolipoproteinsIBA 12/2020 - 01/2013
6	Peptides (Polypeptides)IBA 10/2019 - 05/2007
6	epidermal growth factor receptor VIIIIBA 02/2019 - 07/2013
6	AcidsIBA 01/2019 - 03/2012
6	Histone Deacetylase InhibitorsIBA 12/2017 - 01/2008
6	polylactosamineIBA 01/2017 - 01/2012
5	Indicators and Reagents (Reagents)IBA 06/2022 - 01/2005
5	LipopolysaccharidesIBA 05/2022 - 01/2015
5	GlycosyltransferasesIBA 01/2022 - 12/2012
5	Long Noncoding RNAIBA 01/2022 - 11/2019
5	ChemokinesIBA 01/2022 - 11/2007
5	Histones (Histone)IBA 01/2022 - 11/2012
5	IntegrinsIBA 08/2021 - 12/2017
5	Glutamic Acid (Glutamate)FDA Link 01/2021 - 02/2007
5	Telomerase (Telomerase Reverse Transcriptase)IBA 01/2021 - 01/2004

Therapy/Procedure

60	Therapeutics 01/2022 - 01/2005
16	Radiotherapy 08/2020 - 08/2008
13	Stents 01/2023 - 03/2012
13	Drug Therapy (Chemotherapy) 10/2021 - 01/2015
8	Immunotherapy 01/2021 - 01/2012
7	Transplantation 12/2021 - 06/2003
7	Denervation 01/2021 - 03/2015
7	Percutaneous Coronary Intervention 12/2020 - 10/2006
5	Aftercare (After-Treatment) 01/2022 - 08/2013